Akèy › Kansè nan tete › Georgia › Augusta
Etid klinik pou Kansè nan tete nan Augusta, GA
5 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Augusta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Ap rekriteFaz 1
- Georgia Cancer Center at Augusta University, Augusta
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Augusta Oncology Associates PC-D'Antignac, Augusta
- Augusta Oncology Associates PC-Wheeler, Augusta
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Ap rekriteFaz 2
- Augusta University, Augusta
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Ap rekriteFaz 1/2
- Augusta University Georgia Cancer Center, Augusta
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Ap rekriteFaz 1/2
- Georgia Cancer Center at Augusta University, Augusta
Etid Kansè nan tete nan lòt vil
- New York City, NY134 etid
- Houston, TX126 etid
- Boston, MA111 etid
- Nashville, TN80 etid
- Los Angeles, CA72 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Durham, NC63 etid
- Queens, NY63 etid
- Chicago, IL58 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Augusta
- Leksemi mieloïd egi10 etid
- Kansè ovè8 etid
- Kansè Endomèt7 etid
- Kansè (tout kalite)7 etid
- Maladi selil fòs5 etid
- Miasteni grav4 etid
- Kansè san4 etid
- Limfòm Burkitt4 etid
- Limfom Difize Gwo Selil B4 etid
- Lukemi miyoyid kwonik4 etid
- Limfòm Non-Hodgkin4 etid
- Kansè kol4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.